THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
about
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine neuron activity in a rodent model of schizophrenia susceptibility."Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.
P2860
THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@en
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@nl
type
label
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@en
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@nl
prefLabel
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@en
THC and endocannabinoids diffe ...... ic PCP model of schizophrenia.
@nl
P2860
P356
P1476
THC and endocannabinoids diffe ...... nic PCP model of schizophrenia
@en
P2093
Andrea Giuffrida
Daniel J Lodge
P2860
P304
P356
10.1177/0269881115612239
P407
P577
2015-10-28T00:00:00Z